What are the small molecule drugs?
Generally, small-molecule drugs include nirmatrelvir tablets/ritonavir tablets combination pack, molnupiravir capsules, azvudine tablets, molnupiravir capsules, and methimazole tablets. Small-molecule drugs refer to chemically synthesized drugs with a molecular weight of less than 1,000. The details are as follows:
1. Nirmatrelvir Tablets/Ritonavir Tablets Combination Pack
This product is a combination pack of nirmatrelvir tablets and ritonavir tablets. It is an oral small-molecule antiviral drug for the treatment of SARS-CoV-2 infection, indicated for adult patients with mild to moderate coronavirus disease (COVID-19) who are at high risk for progression to severe illness.
2. Molnupiravir Capsules
Molnupiravir is an oral small-molecule antiviral drug for the treatment of SARS-CoV-2 infection, indicated for adult patients with mild to moderate COVID-19 who are at high risk for progressing to severe disease.
3. Azvudine Tablets
Azvudine tablets are a domestically developed oral small-molecule drug in China for treating SARS-CoV-2 infection, indicated for adult patients with ordinary-type COVID-19.
4. Molnupiravir Capsules
This medication is suitable for adults with mild to moderate COVID-19 who are at high risk of progressing to severe disease, such as those who are elderly, obese (or overweight), or have chronic kidney disease, diabetes, severe cardiovascular disease, chronic obstructive pulmonary disease (COPD), or active cancer.
5. Methimazole Tablets
Methimazole is an antithyroid drug that inhibits the synthesis of thyroid hormones. After oral administration, methimazole suppresses thyroid function, thereby reducing the synthesis and release of thyroid hormones, achieving a therapeutic effect for hyperthyroidism.
Patients should strictly follow the instructions and use these medications under the guidance of a physician. Self-medication is not recommended. If any discomfort occurs, patients should seek medical attention promptly to avoid delays in treatment.